Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Second Edition BOGP (0)
Australia (1)
Neurology/Parkinson's Disease (1)
Other (4)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Continuity and sustainability
Clinical study phase III